Can co-amoxiclav (amoxicillin-clavulanate) and doxycycline be given at the same time?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Co-Amoxiclav and Doxycycline Be Given at the Same Time?

Yes, co-amoxiclav (amoxicillin-clavulanate) and doxycycline can be safely given together when clinically indicated, and this combination is explicitly recommended in multiple infectious disease guidelines for specific infections.

Evidence from Clinical Guidelines

The combination of a beta-lactam antibiotic (like co-amoxiclav) with doxycycline appears in several authoritative guidelines:

Respiratory Infections

For community-acquired pneumonia in outpatients with comorbidities, the 2019 ATS/IDSA guidelines explicitly recommend combination therapy consisting of amoxicillin-clavulanate (500/125 mg three times daily or 875/125 mg twice daily) plus doxycycline (100 mg twice daily) as a first-line option 1. This demonstrates that the combination is not only safe but actively endorsed for appropriate clinical scenarios.

Skin and Soft Tissue Infections

The 2014 IDSA guidelines for skin and soft tissue infections recommend that when coverage for both streptococci and MRSA is desired for oral therapy, options include "the combination of either SMX-TMP or doxycycline with a β-lactam (eg, penicillin, cephalexin, or amoxicillin)" 2. While this specifically mentions amoxicillin rather than co-amoxiclav, the principle of combining doxycycline with beta-lactams is clearly established.

The 2024 WHO essential medicines guidelines list doxycycline as an alternative treatment option for various infections where amoxicillin-clavulanate is also used, including animal bites and certain skin infections 3.

Bronchiectasis Exacerbations

The 2019 British Thoracic Society guidelines list both amoxicillin-clavulanate and doxycycline as treatment options for various pathogens causing bronchiectasis exacerbations, though typically as alternatives rather than in combination 4.

Pharmacological Considerations

No Significant Drug Interactions

A 1989 pharmacokinetic study specifically examined the interaction between doxycycline and amoxicillin-clavulanic acid and found that these antibiotics do not significantly affect each other's bioavailability 5. The study demonstrated that co-administration does not alter the pharmacokinetic parameters of either drug to a clinically meaningful degree.

FDA Drug Label Information

The FDA-approved drug label for amoxicillin-clavulanate does not list doxycycline as a contraindicated or problematic combination 6. The label discusses interactions with probenecid, oral anticoagulants, allopurinol, and oral contraceptives, but makes no mention of tetracyclines or doxycycline as problematic combinations.

Important Clinical Caveats

Anticoagulation Monitoring

If your patient is on warfarin or other coumarin anticoagulants, both amoxicillin-clavulanate and doxycycline independently increase bleeding risk when combined with anticoagulants 7. The relative risk of major bleeding is 3-5 fold for both amoxicillin and amoxicillin/clavulanic acid, and similar for doxycycline. Close INR monitoring is essential when using either antibiotic with anticoagulants, and using both together may compound this risk.

Antacid Considerations

While antacids do not affect amoxicillin-clavulanate absorption, they significantly reduce doxycycline absorption (reducing AUC by approximately 84%) 5. If the patient is taking antacids, separate administration times by at least 2-3 hours, or consider this interaction when choosing antibiotics.

Spectrum Considerations

The combination provides very broad coverage: co-amoxiclav covers beta-lactamase-producing organisms, streptococci, and many gram-negatives, while doxycycline adds atypical coverage (Mycoplasma, Chlamydia, Legionella) and activity against some MRSA strains. This broad spectrum should be reserved for situations where such coverage is genuinely needed, not used empirically without justification, to minimize antimicrobial resistance development.

When This Combination Makes Sense

Use this combination when you need:

  • Coverage for both typical and atypical respiratory pathogens in pneumonia with comorbidities 1
  • Dual coverage for polymicrobial skin infections where both streptococci and potential MRSA are concerns 2
  • Situations where monotherapy has failed and broader coverage is warranted based on clinical deterioration

When to Avoid This Combination

  • Simple infections responding to monotherapy - unnecessary broad spectrum promotes resistance
  • Patients on anticoagulation - unless benefits clearly outweigh bleeding risks with enhanced monitoring
  • Viral infections - neither antibiotic is indicated
  • Pregnancy - doxycycline is relatively contraindicated; use amoxicillin-clavulanate alone 8
  • Children under 8 years - doxycycline causes tooth discoloration 8, 9

References

Related Questions

A patient with persistent cough, chest congestion, and wheezing despite having two days left of Augmentin (amoxicillin‑clavulanate) and a recent 12‑hour flight, with a recent chest X‑ray negative for pneumonia, asks what additional measures can be taken to improve symptoms?
When should Augmentin (amoxicillin‑clavulanate) and doxycycline be prescribed together, and what are the appropriate adult dosing, contraindications, and alternative regimens?
Should amoxicillin/clavulanate (Augmentin) 625 mg be administered three times daily or twice daily in an adult with normal renal function?
Can I substitute a 250 mg/62.5 mg per mL amoxicillin‑clavulanate suspension for the prescribed 125 mg/31.25 mg per 5 mL formulation, and how should the dose be adjusted?
How should I manage an elderly patient with a six‑week productive cough, poor oral intake, and diarrhea after a five‑day course of amoxicillin‑clavulanate (Augmentin)?
Which antidepressant has the lowest discontinuation‑syndrome risk when combined with methylphenidate in an adult with ADHD, autism spectrum disorder, and major depressive disorder?
What is the definition, work‑up, and management of chronic glomerulonephritis?
When should electrohydraulic lithotripsy be used for common bile duct stones and how is the procedure performed?
What are the indications, recommended dosing, contraindications, precautions, and common adverse effects of ondansetron?
Is ondansetron a mood‑elevating medication?
What are the recommended diagnostic and surveillance strategies for individuals suspected of having Lynch syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question